Jiangsu HengRui Medicine Co., Ltd.: Renal Insufficiency, Chronic trials
The registry lists 11 Renal Insufficiency, Chronic studies with Jiangsu HengRui Medicine Co., Ltd. as lead sponsor. 5 are open to participants now and 0 have results posted.
Phase 1 7Phase 2 1Phase 3 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Renal Efficacy and Safety of the Novel Oral Small-Molecule GLP-1RA HRS-7535 Evaluated in Participants With Chronic Kidney DiseaseNot yet recruitingNCT07625774Phase 3
- A Mass Balance Study of [14C]HRS-1780 in Healthy Adult Male SubjectsNot yet recruitingNCT07557407Phase 1
- A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of Patients With Chronic Kidney DiseaseRecruitingNCT07419828Phase 3
- Drug-drug Interaction Study of HRS-1780 Tablets in Healthy SubjectsNot yet recruitingNCT06344936Phase 1
- Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal FunctionNot yet recruitingNCT06039254Phase 1
- Efficacy and Safety of HRS-1780 Tablets and Henagliflozin Proline Tablets in Patients With Chronic Kidney DiseaseCompletedNCT06221059Phase 2
- Safety and Tolerance of Increased Doses of HRS-1780 Tablets in Healthy SubjectsStatus unknownNCT05638126Phase 1
- A Study to Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Secondary HyperparathyroidismStatus unknownNCT04994080Phase 3
- Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Patients With Anemia of Non-dialysis Chronic Kidney Diseases.Status unknownNCT04470063Phase 1
- Food Effect Study of DDO-3055 Tablets in Healthy SubjectsCompletedNCT04197778Phase 1
- A Study to Evaluate the Safety and Efficacy of DDO-3055 in Healthy Volunteers and Patients With Chronic Kidney DiseaseCompletedNCT03976115Phase 1